Molecular Diagnostics Market to Value US$ 13,873.6 Mn at CAGR of 7.1% by 2025 | Exclusive Report by Fortune Business Insights
Key Companies Covered in the Molecular Diagnostics Market are Siemens Healthcare GmbH, BioMérieux SA., Novartis AG, Grifols, S.A., Hoffmann-La Roche Ltd., Danaher, Grifols, S.A., and Hologic Inc.and others
PUNE, India, June 13, 2019 /PRNewswire/ -- Leading organizations such as Danaher, Abbott, F. Hoffmann-La Roche Ltd., and QIAGEN are leading the Global Molecular Diagnostics Market during the period of 2018 to 2025. Factors such as the presence of a robust supply chain network and favourable research and development strategies are enabling these players to establish a strong foothold in the global molecular diagnostics market. Fortune Business Insights confirms the increasing investments in cost management to create great growth opportunities in the market in their report, titled "Molecular Diagnostics Market – Global Market Analysis, Insights, and Forecasts, 2018 – 2025".
Molecular diagnostics emerged as a superior methodology in the past decade since it provides faster diagnosis with minimal complexities. The demand for molecular diagnosis is expected to rise due to the rising prevalence of infectious diseases in both developing and developed nations.
Major outbreaks of bacterial and viral infections in the Middle East and Africa have compelled all government and research institutions worldwide to adopt molecular diagnostics for inhibiting microbial outbreaks.
As per the Fortune Business Insights reports, the Molecular Diagnostics Market is estimated to reach US$ 13,873.6 Mn by 2025 from US$ 8,012.7 Mn in 2017. The report states the global molecular diagnostics market to exhibit a remarkable CAGR of 7.1% within the forecast period of 2018 to 2025.
Infectious Diseases Application Attracting Most Revenue
At present, the increasing incidence of microbial outbreaks is boosting the market for molecular diagnostics. In terms of technique, the amplification techniques segment is anticipated to contribute a major share in the market. The reagent and consumables segment is also expected to grow at a significant rate. By application, the infectious diseases segment was valued at US$ 4,853.0 Mn in 2017.
Awareness programmes aimed at spreading awareness on infectious diseases and relevant preventive measures as adopted by the World Bank, World Health Organization (WHO), and other international organizations are also contributing to the growth of the molecular diagnostics market. Huge amount of resource engagement in terms of expertise, technology, and finance along with favourable environment for the simulation of research projects, especially for infectious diseases will boost the market.
Government Support for Reinforcement to Result in Higher Growth of Market in North America
The presence of major players in North America is likely to help the regional market to dominate at a global level. Besides, the collaborative efforts taken by large academic institutions and hospital research organizations to improve clinical efficiency will also boost the molecular diagnostic market in North America. On the other side, the molecular diagnostics market in Europe is likely to witness remarkable growth owing to the rising adoption of molecular diagnostics by clinical microbiology organizations and bigger hospitals.
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/molecular-diagnostics-market-100086
The market in Asia Pacific is currently at the premature stage, but the rapidly developing healthcare and medical infrastructure and increasing investments in research and development are likely to create growth opportunities for the molecular diagnostics market in Asia Pacific in the coming years.
Key Companies Mentioned in Report
- BioMérieux SA.
- Becton Dickinson
- Danaher
- Grifols, S.A.
- Hologic Inc.
- Novartis AG
- QIAGEN
- Siemens Healthcare GmbH
- Hoffmann-La Roche Ltd.
- Other players
Browse Complete Report Details https://www.fortunebusinessinsights.com/industry-reports/molecular-diagnostics-market-100086
The global molecular diagnostics market is segmented into the following categories:
- Global Molecular Diagnostics Market, by Product Type
- Instruments
- Reagents & Consumables
- Global Molecular Diagnostics Market, by Application
- Infectious Disease
- Blood Screening
- Histology
- Oncology
- Others
- Global Molecular Diagnostics Market, by Technique
- Hospitals Amplification Techniques
- Hybridization Techniques
- Sequencing Techniques
- Others
- Global Molecular Diagnostics Market, by End User
- Clinical & Pathology Labs
- Hospitals
- Others
- Global Molecular Diagnostics Market, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/molecular-diagnostics-market-100086
Browse Related Reports:
- Thrombin Market Size, Share and Global Trend By Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End user (Hospitals, Diagnostics Centers & Clinics, Academics and Research Institutes), and Geography Forecast till 2026
- Antithrombin Market Size, Share and Global Trend By Application (Therapeutics, Research, Diagnostics & Others), Source (Human, Goat Milk), Dosage Form (Lyophilized, Liquid) & Geography Forecast till 2025
- Precision Diagnostics Market Size, Share and Global Trend By Type (Genetic tests, Esoteric tests), End Users (Hospitals, Clinical laboratories) and Geography Forecast till 2026
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com
Photo- https://mma.prnewswire.com/media/902283/MOLECULAR_DIAGNOSTICS_MARKET.jpg
Logo- https://mma.prnewswire.com/media/881202/Fortune_Business_Insights_Logo.jpg
Share this article